Margaret Mordin, William Parrish, Catherine Masaquel, Brad Bisson, Catherine Copley-Merriman
{"title":"Intra-articular Hyaluronic Acid for Osteoarthritis of the Knee in the United States: A Systematic Review of Economic Evaluations.","authors":"Margaret Mordin, William Parrish, Catherine Masaquel, Brad Bisson, Catherine Copley-Merriman","doi":"10.1177/11795441211047284","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The economic impact of intra-articular hyaluronic acid (IAHA) for the treatment of knee pain associated with osteoarthritis (OA) has been evaluated in the United States, but not systematically summarized.</p><p><strong>Objective: </strong>We reviewed the literature to determine the economic impact of IAHA for pain associated with knee OA in the United States.</p><p><strong>Methods: </strong>A literature review was performed in PubMed (including MEDLINE and MEDLINE In-Process), Embase, the Cochrane Database of Systematic Reviews, and National Health Service Economic Evaluation Database and was limited to English language human studies published from January 2000 to October 2020.</p><p><strong>Results: </strong>The literature search identified 215 unique abstracts; of these, 47 were selected for full-text review and 21 studies met the inclusion criteria. Intra-articular hyaluronic acid injections delayed progression to total knee arthroplasty (TKA), and repeated courses of treatment successfully delayed TKA by more than 5 years. Intra-articular hyaluronic acid was found to reduce the use of pain medications overall and reduce the number of patients receiving opioid prescriptions by 6% (<i>P</i> < .001). Several studies showed that IAHA is more cost-effective in treating pain associated with knee OA compared with conventional care with nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids, and several authors concluded that IAHA should be the dominant treatment strategy.</p><p><strong>Conclusions: </strong>Current studies suggest that IAHA may reduce the use of pain medications, such as NSAIDs and opioids, and impact time to TKA procedures, thus potentially decreasing overall treatment costs of knee OA over time. Furthermore, IAHA was determined to be cost-effective against NSAIDs, corticosteroids, analgesics, and conservative treatment. As the safety and efficacy of IAHA for knee OA have been well established, the findings from our literature review may be used to inform future economic evaluations.</p>","PeriodicalId":10443,"journal":{"name":"Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders","volume":"14 ","pages":"11795441211047284"},"PeriodicalIF":1.9000,"publicationDate":"2021-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/e1/10.1177_11795441211047284.PMC8619730.pdf","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11795441211047284","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 8
Abstract
Background: The economic impact of intra-articular hyaluronic acid (IAHA) for the treatment of knee pain associated with osteoarthritis (OA) has been evaluated in the United States, but not systematically summarized.
Objective: We reviewed the literature to determine the economic impact of IAHA for pain associated with knee OA in the United States.
Methods: A literature review was performed in PubMed (including MEDLINE and MEDLINE In-Process), Embase, the Cochrane Database of Systematic Reviews, and National Health Service Economic Evaluation Database and was limited to English language human studies published from January 2000 to October 2020.
Results: The literature search identified 215 unique abstracts; of these, 47 were selected for full-text review and 21 studies met the inclusion criteria. Intra-articular hyaluronic acid injections delayed progression to total knee arthroplasty (TKA), and repeated courses of treatment successfully delayed TKA by more than 5 years. Intra-articular hyaluronic acid was found to reduce the use of pain medications overall and reduce the number of patients receiving opioid prescriptions by 6% (P < .001). Several studies showed that IAHA is more cost-effective in treating pain associated with knee OA compared with conventional care with nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids, and several authors concluded that IAHA should be the dominant treatment strategy.
Conclusions: Current studies suggest that IAHA may reduce the use of pain medications, such as NSAIDs and opioids, and impact time to TKA procedures, thus potentially decreasing overall treatment costs of knee OA over time. Furthermore, IAHA was determined to be cost-effective against NSAIDs, corticosteroids, analgesics, and conservative treatment. As the safety and efficacy of IAHA for knee OA have been well established, the findings from our literature review may be used to inform future economic evaluations.
背景:美国已经对关节内透明质酸(IAHA)治疗骨关节炎(OA)相关膝关节疼痛的经济影响进行了评估,但尚未系统总结。目的:我们回顾了文献,以确定IAHA对美国膝关节OA相关疼痛的经济影响。方法:在PubMed(包括MEDLINE和MEDLINE in - process)、Embase、Cochrane系统评价数据库和国家卫生服务经济评价数据库中进行文献综述,仅限于2000年1月至2020年10月发表的英语人类研究。结果:文献检索鉴定出215篇独特的摘要;其中,47项研究被选为全文综述,21项研究符合纳入标准。关节内透明质酸注射延缓了全膝关节置换术(TKA)的进展,重复疗程的治疗成功地延缓了TKA超过5年。结论:目前的研究表明,IAHA可能会减少非甾体抗炎药和阿片类药物等止痛药的使用,并影响TKA手术的时间,因此随着时间的推移,可能会降低膝关节OA的总体治疗成本。此外,IAHA与非甾体抗炎药、皮质类固醇、镇痛药和保守治疗相比具有成本效益。由于IAHA治疗膝关节OA的安全性和有效性已经得到了很好的证实,我们文献综述的发现可以用于未来的经济评估。